Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07354126Recruiting
Trial of flunarizine and propranolol in migraine (2 arms). Primary endpoint: Pediatric Migraine Disability Assessment Scale score reduction at 3 months. Started Sep 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07354126.